Group
Rare Diseases
4 themes21 tickers
10D rank10D#164of 172 groups/172
Peek into the magic of rare disease healthcare. Our group splits into gene, RNA, and protein therapy themes, plus CNS/neuro breakthroughs. With supportive policies and expanding patient access, this market is buzzing with innovative platforms and growth.
Themes in this group
| Rare Diseases '25: Platform Biotechs & PipelinesPlatform Biotechs & Pipelines | 4 | $26.80B | $107.19B | -0.70% | -3.03% | -8.70% | +2.37% | +15.13% | +41.91% | +100.52% | +244.86% | -0.38% | +9.21% | +11.35% | +84.63% | +5.93% | -4.14% |
| Rare Diseases '25: CNS/NeuroCNS/Neuro | 5 | $28.55B | $142.74B | -1.17% | -4.09% | -10.33% | +1.09% | +23.59% | +49.83% | +4.15% | +105.70% | -1.85% | +13.39% | +6.78% | +85.58% | +0.44% | +4.76% |
| Rare Diseases '25: RNA Therapy & Protein ModRNA Therapy & Protein Mod | 5 | $10.16B | $50.81B | -0.60% | -4.64% | -17.89% | -0.35% | -26.55% | -7.83% | +4.63% | +241.57% | -10.27% | -8.73% | -18.09% | +37.63% | +13.31% | -15.69% |
| Rare Diseases '25: Gene Therapy & Genetic MedGene Therapy & Genetic Med | 7 | $3.26B | $22.85B | +0.69% | -11.93% | -20.58% | +0.81% | +13.36% | +2.27% | +18.59% | -12.55% | -7.51% | -5.01% | +11.87% | +28.18% | +2.46% | -7.79% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary